Research Paper Volume 12, Issue 2 pp 1171—1185

DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection

class="figure-viewer-img"

Figure 4. Progression-free survival analyses by DNASE1L3 expression level. Progression-free survival analyses according to DNASE1L3 status in all patients (A) or according to sex (B), size (C, D), age (E), differentiation level (F), presurgical AFP (G), postsurgical AFP (H), HBsAg level (I) and cirrhosis status (J).